Interactions between pharmaceutical companies and healthcare professionals (HCPs) are essential for advancing patient care and scientific innovation. However, these collaborations are governed by complex and evolving regulations that vary across markets, creating challenges for companies striving to remain compliant while fostering meaningful partnerships.
This webinar will explore the key principles, regulatory frameworks, and ethical considerations that shape pharma-HCP engagements. We will address common pitfalls and practical strategies for ensuring transparency, integrity, and compliance in areas such as scientific exchange, promotional activities, transfers of value, (ToV) and consultancy agreements.
Available from 10 December 2025- register in advance.
Presenter:
Monika Staniulytė is a skilled Regulatory Affairs Expert with 8+ years of experience in the pharmaceutical industry, specializing in regulatory affairs and marketing compliance. She brings a strong understanding of regulatory frameworks and compliance standards, ensuring that products are not only registered but also successfully reach patients. Monika’s expertise covers the entire process: from coordinating regulatory submissions and supporting product launches to overseeing compliance in advertising and interactions with healthcare professionals, and supporting market access activities. Her ability to navigate complex regulations and collaborate across departments makes her a valuable asset in driving compliance and enabling timely product availability.
Participants will gain actionable insights to:
- Ask the right compliance questions before engaging HCPs
- Navigate country-specific regulations and industry codes
- Implement robust processes to ensure ethical and compliant collaborations
Who should attend this webinar?
- Regulatory Affairs professionals
- Medical Affairs teams, Compliance officers
- Commercial teams
- Anyone involved in planning or managing interactions with HCPs.